Routine

Restless legs syndrome

Willis-Ekbom disease · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A sensorimotor disorder with an irresistible urge to move the legs, worse at rest and in the evening and relieved by movement, frequently disrupting sleep. Iron deficiency is a key reversible driver and alpha-2-delta ligands are now preferred first-line pharmacotherapy.

Red flags

  • Augmentation on dopamine agonists
  • New focal neurological signs (reconsider diagnosis)
  • Severe refractory symptoms requiring opioids
  • Suicidal ideation or impulse control disorder on dopamine agonists
  • Underlying iron deficiency from occult bleeding

Assessment

Differential diagnosis

  • Peripheral neuropathy
  • Nocturnal leg cramps
  • Akathisia (drug-induced)
  • Peripheral vascular disease
  • Arthritis or positional discomfort
  • Periodic limb movement disorder

Investigations

  • Serum ferritin and transferrin saturation (treat if ferritin <75 micrograms/L)
  • Renal function (uraemia association)
  • Medication review (antidepressants, antihistamines, dopamine blockers)
  • Glucose/HbA1c and B12 if neuropathy suspected
  • Pregnancy consideration (common and usually transient)

Management

  • Confirm the four core features: urge to move, worse at rest, relieved by movement, evening predominance
  • Check and replace iron, aiming ferritin above 75 micrograms/L even without anaemia
  • Review and withdraw aggravating drugs (SSRIs, antihistamines, metoclopramide)
  • Advise on sleep hygiene, reduced caffeine and alcohol
  • For persistent symptoms, start an alpha-2-delta ligand as first-line
  • Reserve dopamine agonists for selected cases given augmentation risk, at lowest dose
  • Monitor closely for augmentation (earlier, more intense, spreading symptoms)
  • Consider low-dose opioid for severe refractory disease under specialist care
  • Reassess iron periodically
  • Refer refractory or augmented cases to a specialist

Drugs & doses

Ferrous sulfate 325 mg PO daily (with vitamin C) or IV iron if oral fails/ferritin very low
Gabapentin 300 mg PO nocte titrated to 300-900 mg
Pregabalin 75 mg PO nocte titrated to 150-450 mg
Gabapentin enacarbil 600 mg PO daily
Pramipexole 0.125 mg PO nocte or ropinirole 0.25 mg PO nocte (second-line, augmentation risk)
Low-dose oxycodone or targinact for severe refractory cases (specialist)

Disposition

Primary care or outpatient neurology. Refer refractory or augmented cases to a sleep/movement specialist.

Complications & pitfalls

  • Chronic sleep deprivation and daytime impairment
  • Dopaminergic augmentation
  • Impulse control disorders with dopamine agonists
  • Depression and reduced quality of life

Exam pearls

  • Check ferritin in every patient; iron repletion alone can resolve symptoms
  • Alpha-2-delta ligands have replaced dopamine agonists as preferred first-line due to augmentation
  • Augmentation (symptoms creeping earlier in the day) signals dopaminergic overtreatment
  • Many common drugs (antidepressants, antihistamines) worsen RLS

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.